Corrigendum: Patients with myeloproliferative neoplasms harbor high frequencies of CD8 T cell-platelet aggregates associated with T cell suppression

Front Immunol. 2022 Aug 5:13:970322. doi: 10.3389/fimmu.2022.970322. eCollection 2022.

¹ Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Herlev University Hospital, Herlev, Denmark.
² IIB-Sant Pau- Institut Rec. Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
³ Department of Hematology, Zealand University Hospital, Roskilde, Denmark.
⁴ Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
⁵ Department of Laboratory Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA, United States.
⁶ Department of Data and Innovation Support, Region Zealand, Sorø, Denmark.
⁷ Department of Hematology, Rigshospitalet University Hospital, Copenhagen, Denmark.
⁸ Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2022.866610.].

Keywords: CALR mutation; JAK2 mutation; Myeloproliferative Neoplasms (MPN); platelet-T cell aggregates; platelet-bound T cells; platelets.